Monika Tornsen
Directeur/Bestuurslid bij IMMUNIC, INC.
Oorsprong van het eerstegraads netwerk van Monika Tornsen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
17
| Subsidiary | Medical Specialties | 17 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Biotechnology | 15 | |
| Public Company | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Monika Tornsen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Founder Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| 4SC AG | Biotechnology | Chairman Founder Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Sales & Marketing General Counsel | |
| SHIRE | Pharmaceuticals: Major | Public Communications Contact General Counsel Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sanofi-Synthélabo Ltd.
 Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| SOLID BIOSCIENCES INC. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Director/Board Member Director of Finance/CFO | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | President Corporate Officer/Principal | |
| MEDCAP AB | Medical Specialties | Director/Board Member Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Oberlin College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Colorado Boulder | College/University | Undergraduate Degree Doctorate Degree | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Duitsland | 4 |
| Verenigd Koninkrijk | 4 |
| Zweden | 4 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 13 |
| Commercial Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 333 |
| Corporate Officer/Principal | 165 |
| Independent Dir/Board Member | 122 |
| Chairman | 61 |
| Chief Tech/Sci/R&D Officer | 53 |
Sterkste connecties
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Tadataka Yamada | 36 |
| Jörg Neermann | 34 |
| Liam Ratcliffe | 32 |
| Michael Bonney | 32 |
| Elmar Schnee | 31 |
| Mary Gray | 27 |
| Renée Aguiar-Lucander | 26 |
| Eliseo Salinas | 22 |
| Vincent Ossipow | 22 |
| Fred Driscoll | 21 |
| Hilde Furberg | 21 |
| John Martin | 20 |
| David Meeker | 19 |
| Richard Peters | 16 |
- Beurs
- Insiders
- Monika Tornsen
- Bedrijfsconnecties